N Anthony Coles's Net Worth
N Anthony Coles's net worth is estimated to be at least $30,256,262.59 as of 05/03/2024. CoreStreet's estimation of N Anthony Coles's net worth is based on their sale of stock and current holding of stock.
N Anthony Coles is Director at Cerevel Therapeutics Holdings Inc. They have executed at least 18 trades of stock as per SEC Form 4 filings. Their most recent trade was for 50,000 units of CERE stock on 03/04/2024. Their biggest sale was on 09/15/2021 when they sold 11,948 units of Regeneron Pharmaceuticals Inc stock for $7,873,493.04. They typically trade 3 times per year.
Total value of insider buys:
- $0.00
Total value of insider sells:
- $30,256,262.59
Most recent insider trade:
- March 4, 2024
N Anthony Coles's Insider Trading History
| Cerevel Therapeutics Holdings Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 4, 2024 | Director | 50,000 | $41.01 | Sell | $2,050,500.00 |
Feb. 29, 2024 | Director | 50,000 | $41.16 | Sell | $2,058,000.00 |
Feb. 7, 2024 | Director | 2,506 | $41.54 | Sell | $104,099.24 |
Nov. 8, 2023 | Director | 100 | $25.16 | Sell | $2,516.00 |
Nov. 3, 2023 | Director | 61,401 | $25.43 | Sell | $1,561,427.43 |
Sept. 7, 2023 | Director | 50,000 | $24.07 | Sell | $1,203,500.00 |
July 11, 2023 | Director | 50,000 | $30.03 | Sell | $1,501,500.00 |
June 1, 2023 | CEO | 50,000 | $32.60 | Sell | $1,630,000.00 |
May 4, 2023 | CEO | 50,000 | $31.47 | Sell | $1,573,500.00 |
April 11, 2023 | CEO | 50,000 | $25.06 | Sell | $1,253,000.00 |
March 3, 2023 | CEO | 3,000 | $27.19 | Sell | $81,570.00 |
Feb. 7, 2023 | CEO | 50,000 | $33.13 | Sell | $1,656,500.00 |
Jan. 5, 2023 | CEO | 50,000 | $29.94 | Sell | $1,497,000.00 |
Dec. 9, 2022 | CEO | 50,000 | $26.67 | Sell | $1,333,500.00 |
| Regeneron Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 28, 2022 | Director | 5,758 | $714.11 | Sell | $4,111,845.38 |
Sept. 15, 2021 | Director | 11,948 | $658.98 | Sell | $7,873,493.04 |
| McKesson Corporation | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 31, 2018 | Director | 1,350 | $128.69 | Sell | $173,731.50 |
| Amgen Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 5, 2013 | CEO | 6,562 | $90.00 | Sell | $590,580.00 |